ESMO Open (Apr 2019)

Advancing molecular tumour boards: highly needed to maximise the impact of precision medicine

Joris van de Haar,
Louisa Hoes,
Emile Voest

Affiliations

Joris van de Haar: Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Louisa Hoes: Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Emile Voest: Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands

DOI: https://doi.org/10.1136/esmoopen-2019-000516
Journal volume & issue: Vol. 4, no. 2

Abstract

No abstracts available.

Published in ESMO Open

ISSN: 2059-7029 (Online)
Publisher: Elsevier
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.journals.elsevier.com/esmo-open/

About the journal